Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327

Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327

4 Biotech Executives Share Strategies Behind Successful Fund Raises

4 Biotech Executives Share Strategies Behind Successful Fund Raises

Recce Pharmaceuticals higher on positive efficacy data in Murdoch Children’s Research Institute UTI study

Recce Pharmaceuticals higher on positive efficacy data in Murdoch Children’s Research Institute UTI study

Recce Pharmaceuticals — Landmark commitment helps fund R&D costs

Recce Pharmaceuticals — Landmark commitment helps fund R&D costs

Recce secures Australia’s largest-ever $11m Advanced Overseas R&D Finding

Recce secures Australia’s largest-ever $11m Advanced Overseas R&D Finding

Recce Pharmaceuticals awarded A$11 million Advanced Overseas Finding for anti-viral R&D costs

Recce Pharmaceuticals awarded A$11 million Advanced Overseas Finding for anti-viral R&D costs

Recce Pharmaceuticals awarded $43.7 million Advanced Overseas Finding for synthetic anti-infective development program

Recce Pharmaceuticals awarded $43.7 million Advanced Overseas Finding for synthetic anti-infective development program

Recce Pharmaceuticals lead anti-infective R327 shows promise against deadly STD in latest animal study

Recce Pharmaceuticals lead anti-infective R327 shows promise against deadly STD in latest animal study

Antimicrobial resistance with Recce Pharmaceuticals

Antimicrobial resistance with Recce Pharmaceuticals

Engineering the future of antibiotics

Engineering the future of antibiotics